Propel Bio Management »

Madrigal Pharmaceuticals shares owned by Propel Bio Management

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.9M 30k 231.38

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Comm (PAGP)
Applied Therapeutics Comm (APLT)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Crinetics Pharmaceuticals In Comm (CRNX)
Fulcrum Therapeutics Comm (FULC)
Fidelity Inv Mmtrsy 1 680 Comm
Phathom Pharmaceuticals Comm (PHAT)
Day One Biopharmaceuticals I Comm (DAWN)
Ardelyx Comm (ARDX)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Simplify Enhanced Income Comm (HIGH)
Akero Therapeutics Comm (AKRO)
Vanguard Short-term Bond Comm (BSV)

View all positions for Propel Bio Management

Top funds holding Madrigal Pharmaceuticals

Henderson Group
Baker Bros. Advisors
venBio Select Advisor
Vanguard Group
BlackRock
Paulson & Co
Susquehanna International
T. Rowe Price Associates
Alliancebernstein
Artisan Partners Limited Partnership
Jane Street
RA Capital Management
Twin Tree Management
Perceptive Advisors
Norges Bank Investment Management

View all funds holding Madrigal Pharmaceuticals